Cochinchinenin A exhibits significant potential in pharmaceutical research due to its biological activity. It has demonstrated anti-inflammatory and neuroprotective properties, making it a candidate for development in treating neurodegenerative disorders such as Alzheimer's disease. Studies suggest it may inhibit key enzymes involved in oxidative stress and neuronal damage. Additionally, its ability to modulate cellular signaling pathways supports ongoing investigation for use in anti-cancer therapies, particularly in suppressing tumor cell proliferation. Research is also exploring its role as an antioxidant, which could benefit formulations aimed at reducing cellular aging and damage.